Journal of Oncology

Copyright © 2011 Hua-Chuan Zheng and Yasuo Takano. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. A. J. Alberg, M. V. Brock, and J. M. Samet, “Epidemiology of lung cancer: looking to the future,” Journal of Clinical Oncology, vol. 23, no. 14, pp. 3175–3185, 2005. View at Publisher · View at Google Scholar · View at Scopus
2. H. Zheng, H. O. Abdel Aziz, Y. Nakanishi et al., “Oncogenic role of JC virus in lung cancer,” Journal of Pathology, vol. 212, no. 3, pp. 306–315, 2007. View at Publisher · View at Google Scholar · View at Scopus
3. D. Hoffmann, A. Rivenson, and S. S. Hecht, “The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung,” Critical Reviews in Toxicology, vol. 26, no. 2, pp. 199–211, 1996. View at Google Scholar · View at Scopus
4. L. N. Anderson, S. S. Hecht, D. E. Dixon et al., “Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice,” Cancer Research, vol. 49, no. 14, pp. 3770–3775, 1989. View at Google Scholar · View at Scopus
5. L. L. Bedard, G. B. J. Smith, K. R. Reid, D. Petsikas, and T. E. Massey, “Investigation of the role of lipoxygenase in bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung,” Chemical Research in Toxicology, vol. 15, no. 10, pp. 1267–1273, 2002. View at Publisher · View at Google Scholar · View at Scopus
6. Y. Kim, F. Lian, K. J. Yeum et al., “The effects of combined antioxidant (β-carotene, α-tocopherol and ascorbic acid) supplementation on antioxidant capacity, DNA single-strand breaks and levels of insulin-like growth factor-1/IGF-binding protein 3 in the ferret model of lung cancer,” International Journal of Cancer, vol. 120, no. 9, pp. 1847–1854, 2007. View at Publisher · View at Google Scholar · View at Scopus
7. Y. Kim, N. Chongviriyaphan, C. Liu, R. M. Russell, and X.-D. Wang, “Combined antioxidant (β-carotene, α-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model,” Carcinogenesis, vol. 27, no. 7, pp. 1410–1419, 2006. View at Publisher · View at Google Scholar
8. S. A. Belinsky, T. R. Devereux, J. F. Foley, R. R. Maronpot, and M. W. Anderson, “Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse,” Cancer Research, vol. 52, no. 11, pp. 3164–3173, 1992. View at Google Scholar · View at Scopus
9. T. Masi, M. Cekanova, K. Walker et al., “Nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenocarcinomas in Syrian golden hamsters contain beta 2-adrenergic receptor single-nucleotide polymorphisms,” Genes Chromosomes and Cancer, vol. 44, no. 2, pp. 212–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
10. T. Imai, K. Yasuhara, T. Tamura et al., “Inhibitory effects of cinnamaldehyde on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung carcinogenesis in rasH2 mice,” Cancer Letters, vol. 175, no. 1, pp. 9–16, 2002. View at Publisher · View at Google Scholar · View at Scopus
11. A. Hisamoto, E. Kondo, K. Kiura et al., “Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice,” Lung Cancer, vol. 58, no. 1, pp. 15–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
12. C. R. Herzog, D. Desai, and S. Amin, “Array CGH analysis reveals chromosomal aberrations in mouse lung adenocarcinomas induced by the human lung carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone,” Biochemical and Biophysical Research Communications, vol. 341, no. 3, pp. 856–863, 2006. View at Publisher · View at Google Scholar · View at Scopus
13. C. R. Herzog, N. Bodon, B. Pittman et al., “Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: implications for chromosome instability and tumor progression,” Oncogene, vol. 23, no. 17, pp. 3033–3039, 2004. View at Publisher · View at Google Scholar · View at Scopus
14. B. R. Vuillemenot, L. C. Pulling, W. A. Palmisano, J. A. Hutt, and S. A. Belinsky, “Carcinogen exposure differentially modulates RAR-β promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis,” Carcinogenesis, vol. 25, no. 4, pp. 623–629, 2004. View at Publisher · View at Google Scholar · View at Scopus
15. L. C. Pulling, B. R. Vuillemenot, J. A. Hutt, T. R. Devereux, and S. A. Belinsky, “Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens,” Cancer Research, vol. 64, no. 11, pp. 3844–3848, 2004. View at Publisher · View at Google Scholar · View at Scopus
16. B. R. Vuillemenot, L. C. Pulling, W. A. Palmisano, J. A. Hutt, and S. A. Belinsky, “Carcinogen exposure differentially modulates RAR-β promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis,” Carcinogenesis, vol. 25, no. 4, pp. 623–629, 2004. View at Publisher · View at Google Scholar · View at Scopus
17. S. Kalscheuer, X. Zhang, Y. Zeng, and P. Upadhyaya, “Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone,” Carcinogenesis, vol. 29, no. 12, pp. 2394–2399, 2008. View at Publisher · View at Google Scholar · View at Scopus
18. J. D. Bortner Jr., A. Das, T. M. Umstead et al., “Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysis,” Journal of Proteome Research, vol. 8, no. 8, pp. 4050–4061, 2009. View at Publisher · View at Google Scholar · View at Scopus
19. B. Ye, Y. X. Zhang, F. Yang et al., “Induction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanate,” BMC Cancer, vol. 7, article 90, 2007. View at Publisher · View at Google Scholar · View at Scopus
20. H. M. Schuller, P. K. Tithof, M. Williams, and H. Plummer, “The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone is a β-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via β-adrenergic receptor-mediated release of arachidonic acid,” Cancer Research, vol. 59, no. 18, pp. 4510–4515, 1999. View at Google Scholar · View at Scopus
21. C. L. K. Sabourin, Q. S. Wang, S. L. Ralston et al., “Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone-induced mouse lung tumors,” Experimental Lung Research, vol. 24, no. 4, pp. 499–521, 1998. View at Google Scholar · View at Scopus
22. R. Ilona Linnoila, E. Szabo, F. Demayo, H. Witschi, C. Sabourin, and AL. Malkinson, “The role of CC10 in pulmonary carcinogenesis: from a marker to tumor suppression,” Annals of the New York Academy of Sciences, vol. 923, pp. 249–267, 2000. View at Google Scholar · View at Scopus
23. F. Kassie, L. B. Anderson, R. Scherber et al., “Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels,” Cancer Research, vol. 67, no. 13, pp. 6502–6511, 2007. View at Publisher · View at Google Scholar · View at Scopus
24. L. P. Stabile, J. S. Lyker, S. R. Land, S. Dacic, B. A. Zamboni, and J. M. Siegfried, “Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer,” Carcinogenesis, vol. 27, no. 8, pp. 1547–1555, 2006. View at Publisher · View at Google Scholar · View at Scopus
25. A. Ehrhardt, T. Bartels, R. Klocke, D. Paul, and R. Halter, “Increased susceptibility to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in transgenic mice overexpressing c-myc and epidermal growth factor in alveolar type II cells,” Journal of Cancer Research and Clinical Oncology, vol. 129, no. 2, pp. 71–75, 2003. View at Google Scholar · View at Scopus
26. R. A. Lubet, Z. Zhang, R. W. Wiseman, and M. You, “Use of p53 transgenic mice in the development of cancer models for multiple purposes,” Experimental Lung Research, vol. 26, no. 8, pp. 581–593, 2000. View at Publisher · View at Google Scholar · View at Scopus
27. M. D. Siwicky, J. J. Petrik, and R. A. Moorehead, “The function of IGF-IR in NNK-mediated lung tumorigenesis,” Lung Cancer, vol. 71, no. 1, pp. 11–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
28. H. O. Abdel-Aziz, Y. Murai, I. Takasaki et al., “Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study,” Journal of Cancer Research and Clinical Oncology, vol. 134, no. 7, pp. 777–788, 2008. View at Publisher · View at Google Scholar · View at Scopus
29. H. O. Abdel-Aziz, I. Takasaki, Y. Tabuchi et al., “High-density oligonucleotide microarrays and functional network analysis reveal extended lung carcinogenesis pathway maps and multiple interacting genes in NNK [4-(methylnitrosamino)-1-(3-pyridyle)-1-butanone] induced CD1 mouse lung tumor,” Journal of Cancer Research and Clinical Oncology, vol. 133, no. 2, pp. 107–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
30. L. Liu, X. Qin, and S. L. Gerson, “Reduced lung tumorigenesis in human methylguanine DNA-methyltransferase transgenic mice achieved by expression of transgene within the target cell,” Carcinogenesis, vol. 20, no. 2, pp. 279–284, 1999. View at Publisher · View at Google Scholar · View at Scopus
31. L. E. Sandercock, J. N. Hahn, L. Li et al., “Mgmt deficiency alters the in vivo mutational spectrum of tissues exposed to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK),” Carcinogenesis, vol. 29, no. 4, pp. 866–874, 2008. View at Publisher · View at Google Scholar · View at Scopus
32. M. Igarashi, M. Watanabe, M. Yoshida et al., “Enhancement of lung carcinogenesis initiated with 4-(N- hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone by Ogg1 gene deficiency in female, but not male, mice,” Journal of Toxicological Sciences, vol. 34, no. 2, pp. 163–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
33. M. C. Hollander, A. R. Balogh, J. Liwanag et al., “Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice,” Neoplasia, vol. 10, no. 8, pp. 866–872, 2008. View at Publisher · View at Google Scholar · View at Scopus
34. J. Fujimoto, H. Kadara, T. Men, C. van Pelt, D. Lotan, and R. Lotan, “Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice,” PLoS ONE, vol. 5, no. 7, Article ID e11847, 2010. View at Publisher · View at Google Scholar
35. Y. Y. Kim, L. von Weymarn, O. Larsson et al., “Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint in lung tumor defense,” Cancer Research, vol. 69, no. 21, pp. 8455–8462, 2009. View at Publisher · View at Google Scholar · View at Scopus
36. Y. Yang, Z. Zhang, A. B. Mukherjee, and R. I. Linnoila, “Increased susceptibility of mice lacking Clara cell 10-kDa protein to lung tumorigenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a potent carcinogen in cigarette smoke,” Journal of Biological Chemistry, vol. 279, no. 28, pp. 29336–29340, 2004. View at Publisher · View at Google Scholar · View at Scopus
37. Y. Weng, C. Fang, R. J. Turesky, M. Behr, L. S. Kaminsky, and X. Ding, “Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice,” Cancer Research, vol. 67, no. 16, pp. 7825–7832, 2007. View at Publisher · View at Google Scholar · View at Scopus
38. T. Kanehira, T. Tani, T. Takagi, Y. Nakano, E. F. Howard, and M. Tamura, “Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: Involvement of transforming growth factor-β-dependent cell growth attenuation,” Cancer Research, vol. 65, no. 17, pp. 7660–7665, 2005. View at Publisher · View at Google Scholar · View at Scopus
39. B. Prokopczyk, J. G. Rosa, D. Desai et al., “Chemoprevention of lung tumorigenesis induced by a mixture of benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate,” Cancer Letters, vol. 161, no. 1, pp. 35–46, 2000. View at Publisher · View at Google Scholar · View at Scopus
40. J. P. Richie Jr., W. Kleinman, D. H. Desai et al., “The organoselenium compound 1,4-phenylenebis(methylene)selenocyanate inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorgenesis and enhances glutathione-related antioxidant levels in A/J mouse lung,” Chemico-Biological Interactions, vol. 161, no. 2, pp. 93–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
41. A. Das, D. Desai, B. Pittman, S. Amin, and K. El-Bayoumy, “Comparison of the chemopreventive efficacies of 1,4-phenylenebis(methylene)selenocyanate and selenium-enriched yeast on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mouse,” Nutrition and Cancer, vol. 46, no. 2, pp. 179–185, 2003. View at Google Scholar · View at Scopus
42. L. Li, Y. Xie, W. M. El-Sayed, J. G. Szakacs, M. R. Franklin, and J. C. Roberts, “Chemopreventive activity of selenocysteine prodrugs against tobacco-derived nitrosamine (NNK) induced lung tumors in the A/J mouse,” Journal of Biochemical and Molecular Toxicology, vol. 19, no. 6, pp. 396–405, 2005. View at Publisher · View at Google Scholar · View at Scopus
43. J. H. Weisburger and F. L. Chung, “Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols,” Food and Chemical Toxicology, vol. 40, no. 8, pp. 1145–1154, 2002. View at Publisher · View at Google Scholar · View at Scopus
44. J. Liao, G. Y. Yang, E. S. Park et al., “Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea,” Nutrition and Cancer, vol. 48, no. 1, pp. 44–53, 2004. View at Google Scholar · View at Scopus
45. F. L. Chung, “The prevention of lung cancer induced by a tobacco-specific carcinogen in rodents by green and black tea,” Proceedings of the Society for Experimental Biology and Medicine, vol. 220, no. 4, pp. 244–248, 1999. View at Google Scholar · View at Scopus
46. G. Lu, J. Liao, G. Yang, K. R. Reuhl, X. Hao, and C. S. Yang, “Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine,” Cancer Research, vol. 66, no. 23, pp. 11494–11501, 2006. View at Publisher · View at Google Scholar · View at Scopus
47. T. Yano, S. Yajima, T. Nakamura, S. Horikawa, M. Kishimoto, and T. Ichikawa, “The inhibitory effect of vitamin E on 4-(methylnitrosamino)- 1-(3- pyridyl)-1-butanone-induced DNA injury and the fixation of the DNA injury in mouse lungs,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 358, no. 2, pp. 275–278, 1998. View at Google Scholar · View at Scopus
48. T. Yano, Y. Yano, S. Yajima et al., “The suppression of ornithine decarboxylase expression and cell proliferation at the promotion stage of lung tumorigenesis in mice by α-tocopheryloxybutyric acid,” Biochemical Pharmacology, vol. 61, no. 9, pp. 1177–1181, 2001. View at Publisher · View at Google Scholar · View at Scopus
49. M. Kishimoto, Y. Yano, S. Yajima, S. Otani, T. Ichikawa, and T. Yano, “The inhibitory effect of vitamin E on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in mice based on the regulation of polyamine metabolism,” Cancer Letters, vol. 126, no. 2, pp. 173–178, 1998. View at Publisher · View at Google Scholar · View at Scopus
50. G. Lu, H. Xiao, G. X. Li et al., “A γ-tocopherol-rich mixture of tocopherols inhibits chemically induced lung tumorigenesis in A/J mice and xenograft tumor growth,” Carcinogenesis, vol. 31, no. 4, pp. 687–694, 2010. View at Publisher · View at Google Scholar · View at Scopus
51. H. Mernitz, D. E. Smith, R. J. Wood, R. M. Russell, and X. D. Wang, “Inhibition of lung carcinogenesis by 1α,25-dihydroxyvitamin D and 9-cis retinoic acid in the A/J mouse model: evidence of retinoid mitigation of vitamin D toxicity,” International Journal of Cancer, vol. 120, no. 7, pp. 1402–1409, 2007. View at Publisher · View at Google Scholar · View at Scopus
52. A. R. Dahl, I. M. Grossi, D. P. Houchens et al., “Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study,” Clinical Cancer Research, vol. 6, no. 8, pp. 3015–3024, 2000. View at Google Scholar · View at Scopus
53. H. Mernitz, D. E. Smith, A. X. Zhu, and X. D. Wang, “9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-β but no change in cyclooxygenase-2,” Cancer Letters, vol. 244, no. 1, pp. 101–108, 2006. View at Publisher · View at Google Scholar · View at Scopus
54. H. Mori, K. Matsunaga, Y. Tanakamaru et al., “Effects of protocatechuic acid, S-methylmethanethiosulfonate or 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone(KYN-54) on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in mice,” Cancer Letters, vol. 135, no. 2, pp. 123–127, 1999. View at Publisher · View at Google Scholar · View at Scopus
55. S. Phutthaphadoong, Y. Yamada, A. Hirata et al., “Chemopreventive effects of fermented brown rice and rice bran against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in female A/J mice,” Oncology Reports, vol. 21, no. 2, pp. 321–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
56. H. Y. Lee, S. H. Oh, J. K. Woo et al., “Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis,” Journal of the National Cancer Institute, vol. 97, no. 22, pp. 1695–1699, 2005. View at Publisher · View at Google Scholar · View at Scopus
57. H. C. Chang, Y. C. Huang, and W. C. Hung, “Antiproliferative and chemopreventive effects of adlay seed on lung cancer in vitro and in vivo,” Journal of Agricultural and Food Chemistry, vol. 51, no. 12, pp. 3656–3660, 2003. View at Publisher · View at Google Scholar · View at Scopus
58. J. L. Kyung, W. S. Dong, C. C. Young, and G. J. Hye, “Chemopreventive effect of saponins derived from roots of Platycodon grandiflorum on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice,” Archives of Pharmacal Research, vol. 29, no. 8, pp. 651–656, 2006. View at Google Scholar · View at Scopus
59. J. H. Kim, H. J. Lee, G. S. Kim et al., “Inhibitory effects of 7-hydroxy-3-methoxy-cadalene on 4- (methylinitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice,” Cancer Letters, vol. 213, no. 2, pp. 139–145, 2004. View at Publisher · View at Google Scholar · View at Scopus
60. T. E. Johnson, F. Kassie, M. G. O'Sullivan et al., “Chemopreventive effect of kava on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumorigenesis in A/J mice,” Cancer Prevention Research (Philadelphia, Pa.), vol. 1, no. 6, pp. 430–438, 2008. View at Publisher · View at Google Scholar · View at Scopus
61. C. C. Conaway, C. X. Wang, B. Pittman et al., “Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice,” Cancer Research, vol. 65, no. 18, pp. 8548–8557, 2005. View at Publisher · View at Google Scholar · View at Scopus
62. F. L. Chung, “Chemoprevention of lung cancer by isothiocyanates and their conjugates in A/J mouse,” Experimental Lung Research, vol. 27, no. 3, pp. 319–330, 2001. View at Google Scholar · View at Scopus
63. H. Kohno, M. Taima, T. Sumida, Y. Azuma, H. Ogawa, and T. Tanaka, “Inhibitory effect of mandarin juice rich in β-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice,” Cancer Letters, vol. 174, no. 2, pp. 141–150, 2001. View at Publisher · View at Google Scholar · View at Scopus
64. H. A. N. Al-Wadei and H. M. Schuller, “β-carotene promotes the development of NNK-induced small airway-derived lung adenocarcinoma,” European Journal of Cancer, vol. 45, no. 7, pp. 1257–1264, 2009. View at Publisher · View at Google Scholar · View at Scopus
65. S. A. Matzinger, K. A. Crist, G. D. Stoner et al., “K-ras mutations in lung tumors from A/J and A/JxTSG-p53 F mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate,” Carcinogenesis, vol. 16, no. 10, pp. 2487–2492, 1995. View at Google Scholar · View at Scopus
66. M. Yokohira, H. Takeuchi, K. Saoo et al., “Establishment of a bioassay model for lung cancer chemoprevention initiated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female A/J mice,” Experimental and Toxicologic Pathology, vol. 60, no. 6, pp. 469–473, 2008. View at Publisher · View at Google Scholar · View at Scopus
67. H. Takeuchi, K. Saoo, M. Yokohira et al., “Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-Pyridyl)-1-butanone in female A/J mice,” Cancer Research, vol. 63, no. 22, pp. 7581–7583, 2003. View at Google Scholar · View at Scopus
68. T. Kuno, M. Yokohira, Y. Matsuda et al., “Lack of modifying potential of 8-methoxypsoralen in the promotion or progression stages of lung carcinogenesis in A/J female mice,” Oncology Reports, vol. 20, no. 4, pp. 767–772, 2008. View at Publisher · View at Google Scholar · View at Scopus
69. T. Kamataki, M. Fujieda, K. Kiyotani, S. Iwano, and H. Kunitoh, “Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk,” Biochemical and Biophysical Research Communications, vol. 338, no. 1, pp. 306–310, 2005. View at Publisher · View at Google Scholar · View at Scopus
70. H. M. Schuller, G. Kabalka, G. Smith, A. Mereddy, M. Akula, and M. Cekanova, “Detection of overexpressed COX-2 in precancerous lesions of hamster pancreas and lungs by molecular imaging: implications for early diagnosis and prevention,” ChemMedChem, vol. 1, no. 6, pp. 603–610, 2006. View at Publisher · View at Google Scholar · View at Scopus
71. R. Yao, N. Rioux, A. Castonguay, and M. You, “Inhibition of COX-2 and induction of apoptosis: Two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis,” Experimental Lung Research, vol. 26, no. 8, pp. 731–742, 2000. View at Publisher · View at Google Scholar · View at Scopus
72. L. E. Lantry, Z. Zhang, K. A. Crist et al., “Chemopreventive efficacy of promising farnesyltransferase inhibitors,” Experimental Lung Research, vol. 26, no. 8, pp. 773–790, 2000. View at Publisher · View at Google Scholar · View at Scopus
73. H. Mernitz, F. Lian, D. E. Smith, S. N. Meydani, and X. D. Wang, “Fish oil supplementation inhibits NNK-induced lung carcinogenesis in the A/J mouse,” Nutrition and Cancer, vol. 61, no. 5, pp. 663–669, 2009. View at Publisher · View at Google Scholar · View at Scopus
74. T. Yamaki, T. Yano, H. Satoh et al., “High oleic acid oil suppresses lung tumorigenesis in mice through the modulation of extracellular signal-regulated kinase cascade,” Lipids, vol. 37, no. 8, pp. 783–788, 2002. View at Google Scholar · View at Scopus
75. H. Witschi, I. Espiritu, M. Ly, and D. Uyeminami, “The effects of dietary myoinositol on lung tumor development in tobacco smoke-exposed mice,” Inhalation Toxicology, vol. 16, no. 4, pp. 195–201, 2004. View at Publisher · View at Google Scholar · View at Scopus
76. D. Kishino, K. Kiura, N. Takigawa et al., “Effect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mice,” Lung Cancer, vol. 65, no. 3, pp. 284–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
77. C. A. Granville, N. Warfel, J. Tsurutani et al., “Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen—induced murine lung tumors,” Clinical Cancer Research, vol. 13, no. 7, pp. 2281–2289, 2007. View at Publisher · View at Google Scholar · View at Scopus
78. M. A. Pereira, P. M. Kramer, R. Nines et al., “Prevention of mouse lung tumors by targretin,” International Journal of Cancer, vol. 118, no. 9, pp. 2359–2362, 2006. View at Publisher · View at Google Scholar · View at Scopus
79. D. Desai, A. Das, L. Cohen, K. El-Bayoumy, and S. Amin, “Chemopreventive efficacy of suberoylanilide hydroxamic acid (SAHA) against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice,” Anticancer Research, vol. 23, no. 1A, pp. 499–503, 2003. View at Google Scholar · View at Scopus